Balanced news tone
News Sentiment
ALEC sentiment intelligence
Alector Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-21.8% over one week, +5.2% over four weeks, trend inactive, and below fair value.
Alector (ALEC) Proxy filing Summary
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Alector (ALEC) director receives 28,700 RSUs and 9,450-share option grant
Alector, Inc. director Richard H. Scheller received 28,700 restricted stock units (RSUs) and a stock option for 9,450 shares of common stock, as detailed in a recent Form 4 SEC filing. The RSUs vest on the earlier of June 17, 2027, or the company's next annual stockholder meeting
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 02:39
- Source
- Stock Titan
Alector (NASDAQ: ALEC) director receives RSU and stock option grants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
Equity grants lift Alector (ALEC) director Errol DeSouza’s holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
Alector (ALEC) director awarded stock and options vesting through 2027
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
This Insider Has Just Sold Shares In Alector
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- simplywall.st
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Alector (ALEC) Reports Q1 Loss, Lags Revenue Estimates
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 07 May 2026 23:05
- Source
- Zacks
Alector: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 21:05
- Source
- Associated Press
Alector Reports First Quarter 2026 Financial Results and Provides Business Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 20:05
- Source
- GlobeNewswire
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Morgan Stanley raises Alector stock price target on pipeline focus
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 01 May 2026 07:00
- Source
- Investing.com
Alector drops GSK-partnered Alzheimer’s drug (ALEC:NASDAQ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Seeking Alpha
How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution Risk
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Alector stock upgraded at Cantor Fitzgerald (ALEC:NASDAQ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Seeking Alpha
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Alector Stock Jumps On Upgrade, But AL101 Interim Data Will Be Key (NASDAQ:ALEC)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 11 Mar 2026 07:00
- Source
- Seeking Alpha
There's No Escaping Alector, Inc.'s (NASDAQ:ALEC) Muted Revenues Despite A 32% Share Price Rise
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jan 2026 08:00
- Source
- simplywall.st
Alector (ALEC) Is Down 54.3% After Latozinemab Phase 3 Failure and Major Restructuring – Has The Bull Case Changed?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Oct 2025 07:00
- Source
- simplywall.st
Alector (ALEC) Stock Forecast and Price Target 2026 $ALEC
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 May 2024 13:36
- Source
- MarketBeat
Alector (ALEC) Short Interest & Short Float | Updated Jul 2026 $ALEC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Aug 2020 21:39
- Source
- MarketBeat